Last data update: Apr 18, 2025. (Total: 49119 publications since 2009)
Records 1-7 (of 7 Records) |
Query Trace: Tapp L[original query] |
---|
Self-Reported Mask Use among Persons with or without SARS CoV-2 Vaccination -United States, December 2020-August 2021 (preprint)
Calamari LE , Weintraub WS , Santos R , Gibbs M , Bertoni AG , Ward LM , Saydah S , Plumb ID , Runyon MS , Wierzba TF , Sanders JW , Herrington D , Espeland MA , Williamson J , Mongraw-Chaffin M , Bertoni A , Alexander-Miller MA , Castri P , Mathews A , Munawar I , Seals AL , Ostasiewski B , Ballard CAP , Gurcan M , Ivanov A , Zapata GM , Westcott M , Blinson K , Blinson L , Mistysyn M , Davis D , Doomy L , Henderson P , Jessup A , Lane K , Levine B , McCanless J , McDaniel S , Melius K , O'Neill C , Pack A , Rathee R , Rushing S , Sheets J , Soots S , Wall M , Wheeler S , White J , Wilkerson L , Wilson R , Wilson K , Burcombe D , Saylor G , Lunn M , Ordonez K , O'Steen A , Wagner L , McCurdy LH , Gibbs MA , Taylor YJ , Calamari L , Tapp H , Ahmed A , Brennan M , Munn L , Dantuluri KL , Hetherington T , Lu LC , Dunn C , Hogg M , Price A , Leonidas M , Manning M , Rossman W , Gohs FX , Harris A , Priem JS , Tochiki P , Wellinsky N , Silva C , Ludden T , Hernandez J , Spencer K , McAlister L , Weintraub W , Miller K , Washington C , Moses A , Dolman S , Zelaya-Portillo J , Erkus J , Blumenthal J , Romero Barrientos RE , Bennett S , Shah S , Mathur S , Boxley C , Kolm P , Franklin E , Ahmed N , Larsen M , Oberhelman R , Keating J , Kissinger P , Schieffelin J , Yukich J , Beron A , Teigen J , Kotloff K , Chen WH , Friedman-Klabanoff D , Berry AA , Powell H , Roane L , Datar R , Correa A , Navalkele B , Min YI , Castillo A , Ward L , Santos RP , Anugu P , Gao Y , Green J , Sandlin R , Moore D , Drake L , Horton D , Johnson KL , Stover M , Lagarde WH , Daniel L , Maguire PD , Hanlon CL , McFayden L , Rigo I , Hines K , Smith L , Harris M , Lissor B , Cook V , Eversole M , Herrin T , Murphy D , Kinney L , Diehl P , Abromitis N , Pierre TSt , Heckman B , Evans D , March J , Whitlock B , Moore W , Arthur S , Conway J , Gallaher TR , Johanson M , Brown S , Dixon T , Reavis M , Henderson S , Zimmer M , Oliver D , Jackson K , Menon M , Bishop B , Roeth R , King-Thiele R , Hamrick TS , Ihmeidan A , Hinkelman A , Okafor C , Bray Brown RB , Brewster A , Bouyi D , Lamont K , Yoshinaga K , Vinod P , Peela AS , Denbel G , Lo J , Mayet-Khan M , Mittal A , Motwani R , Raafat M , Schultz E , Joseph A , Parkeh A , Patel D , Afridi B , Uschner D , Edelstein SL , Santacatterina M , Strylewicz G , Burke B , Gunaratne M , Turney M , Zhou SQ , Tjaden AH , Fette L , Buahin A , Bott M , Graziani S , Soni A , Mores C , Porzucek A , Laborde R , Acharya P , Guill L , Lamphier D , Schaefer A , Satterwhite WM , McKeague A , Ward J , Naranjo DP , Darko N , Castellon K , Brink R , Shehzad H , Kuprianov D , McGlasson D , Hayes D , Edwards S , Daphnis S , Todd B , Goodwin A , Berkelman R , Hanson K , Zeger S , Hopkins J , Reilly C , Edwards K , Gayle H , Redd S . medRxiv 2022 10 Wearing a facemask can help to decrease the transmission of COVID-19. We investigated self-reported mask use among subjects aged 18 years and older participating in the COVID-19 Community Research Partnership (CRP), a prospective longitudinal COVID-19 surveillance study in the mid-Atlantic and southeastern United States. We included those participants who completed >=5 daily surveys each month from December 1, 2020 through August 31, 2021. Mask use was defined as self-reported use of a face mask or face covering on every interaction with others outside the household within a distance of less than 6 feet. Participants were considered vaccinated if they reported receiving >=1 COVID-19 vaccine dose. Participants (n=17,522) were 91% non-Hispanic White, 68% female, median age 57 years, 26% healthcare workers, with 95% self-reported receiving >=1 COVID-19 vaccine dose through August; mean daily survey response was 85%. Mask use was higher among vaccinated than unvaccinated participants across the study period, regardless of the month of the first dose. Mask use remained relatively stable from December 2020 through April (range 71-80% unvaccinated; 86-93% vaccinated) and declined in both groups beginning in mid-May 2021 to 34% and 42% respectively in June 2021; mask use has increased again since July 2021. Mask use by all was lower during weekends and on Christmas and Easter, regardless of vaccination status. Independent predictors of higher mask use were vaccination, age >=65 years, female sex, racial or ethnic minority group, and healthcare worker occupation, whereas a history of self-reported prior COVID-19 illness was associated with lower use. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license. |
Evaluation of skin and respiratory symptoms among employees with occupational exposures to cobalt and chromium at an orthopedic implant manufacturer
Beaucham CC , Tapp LC , Mueller CA . J Occup Environ Med 2018 60 (11) e626-e632 The National Institute for Occupational Safety and Health (NIOSH) Health Hazard Evaluation Program received a request from employees at an orthopedic implant manufacturer. Employees were concerned about respiratory symptoms thought to be caused by occupational exposures to metals and metalworking fluids (MWFs). The company manufactured surgical instrumentation and medical devices including cobalt-chromium femoral implants for use in joint replacement surgeries. At the time of the evaluation, the company employed 400 employees spread across nine buildings, working two 8-hour shifts per day, 5 or 6 days per week. Twenty-six employees worked in the building where the implants were machined. |
Synthetic cannabinoid and mitragynine exposure of law enforcement agents during the raid of an illegal laboratory - Nevada, 2014
Tapp L , Ramsey JG , Wen A , Gerona R . MMWR Morb Mortal Wkly Rep 2017 66 (47) 1291-1294 Synthetic cannabinoids (SCs), commonly known by the street name "Spice," are designer drugs of abuse that mimic the psychoactive effects of marijuana. Intentional SC use has resulted in multiple toxicities (1,2), but little is known about occupational SC exposure. After a federal agency's law enforcement personnel in Nevada reported irritability and feeling "high" after raiding illegal SC laboratories and processing seized SCs, a request for a health hazard evaluation was made by the agency to CDC's National Institute for Occupational Safety and Health (NIOSH) in 2014 to evaluate agents' occupational SC exposures. After making the request for a health hazard evaluation, federal agents conducted a raid of an illegal SC laboratory, with assistance from local law enforcement and Drug Enforcement Administration (DEA) personnel and with NIOSH investigators observing from a distance. After the raid, agents collected and processed material evidence. NIOSH investigators tested agents' urine for SC levels before and after the raid and measured SCs in the air and on surfaces after the raid. DEA determined that AB-PINACA (an SC compound) and mitragynine (a plant material with opium-like effects, also known as "kratom") were present in the illegal laboratory. AB-PINACA, its metabolites, and mitragynine were not detected in agents' urine before the raid; however, one or more of these substances was found in the urine of six of nine agents after the raid and processing of the SC evidence. AB-PINACA was detected in one surface wipe sample from the SC laboratory; none was detected in the air in the laboratory or in the offices of the law enforcement agency where the materials were processed after the raid. No policies were in place regarding work practices and use of personal protective equipment (PPE) during raids and evidence processing. To protect agents from SC exposures, NIOSH recommended that the agency require agents to wear a minimum level of PPE (e.g., protective gloves and disposable clothing) and undergo training in PPE and in handling and storing of contaminated evidence from SC laboratory raids. Showers and locker rooms also need to be provided so that agents can reduce contamination and prevent take-home exposure. |
Occupational traumatic injuries among workers in health care facilities - United States, 2012-2014
Gomaa AE , Tapp LC , Luckhaupt SE , Vanoli K , Sarmiento RF , Raudabaugh WM , Nowlin S , Sprigg SM . MMWR Morb Mortal Wkly Rep 2015 64 (15) 405-10 In 2013, one in five reported nonfatal occupational injuries occurred among workers in the health care and social assistance industry, the highest number of such injuries reported for all private industries. In 2011, U.S. health care personnel experienced seven times the national rate of musculoskeletal disorders compared with all other private sector workers. To reduce the number of preventable injuries among health care personnel, CDC's National Institute for Occupational Safety and Health (NIOSH), with collaborating partners, created the Occupational Health Safety Network (OHSN) to collect detailed injury data to help target prevention efforts. OHSN, a free, voluntary surveillance system for health care facilities, enables prompt and secure tracking of occupational injuries by type, occupation, location, and risk factors. This report describes OHSN and reports on current findings for three types of injuries. A total of 112 U.S. facilities reported 10,680 OSHA-recordable* patient handling and movement (4,674 injuries); slips, trips, and falls (3,972 injuries); and workplace violence (2,034 injuries) injuries occurring from January 1, 2012-September 30, 2014. Incidence rates for patient handling; slips, trips, and falls; and workplace violence were 11.3, 9.6, and 4.9 incidents per 10,000 worker-months,dagger respectively. Nurse assistants and nurses had the highest injury rates of all occupations examined. Focused interventions could mitigate some injuries. Data analyzed through OHSN identify where resources, such as lifting equipment and training, can be directed to potentially reduce patient handling injuries. Using OHSN can guide institutional and national interventions to protect health care personnel from common, disabling, preventable injuries. |
Case studies: evaluation of cut-resistant sleeves and possible fiberglass fiber shedding at a steel mill
Ceballos DM , Tapp LC , Wiegand DM . J Occup Environ Hyg 2014 11 (2) D28-33 The National Institute for Occupational Safety and Health (NIOSH) received a health hazard evaluation (HHE) request from employees and union representatives at a steel mill. They were concerned with skin and upper respiratory irritation, and safety and hygiene issues regarding the required use of cut-resistant protective sleeves. The manufacturer of the cut-resistant sleeves reported that the sleeves were made of a blended weave of para-aramid (Kevlar), cellulose, and E-glass fibers. New sleeves were shown to emit very few fibers into the air under controlled use conditions.(1) However, employees were concerned that the sleeves could shed respirable fiberglass fibers, that this shedding could increase after repeated launderings, and that this exposure could cause skin irritation, respiratory irritation, or chronic respiratory disease. | During our evaluation, we met with union representatives and company health and safety managers, toured the facility, and confidentially interviewed employees. We collected surface samples using either Stick-to-it lift tape (SKC Inc., Eighty Four, Pa.) or vacuuming with a polycarbonate filter from work surfaces, workers’ skin, and workers’ clothing, including the surface of new and laundered protective sleeves. We also collected bulk samples of new and laundered protective sleeves and other potential sources of fibers at the steel mill (i.e., insulation materials). These samples were analyzed by stereomicroscope and polarized light microscopy for identification of fiberglass, Kevlar, and cellulose fibers, as well as for fiber morphology and size. This case study focuses on the industrial hygiene sampling component of our evaluation. Information regarding the medical interviews, and safety and hygiene issues related to the use of the sleeves can be found in the NIOSH HHE report. (2) |
Skin and respiratory symptoms in peanut inspectors with peanut dust and endotoxin exposure
Tapp L , Sylvain D . J Occup Environ Hyg 2012 10 (2) D19-24 The National Institute for Occupational Safety and Health (NIOSH) provided technical assistance at a peanut grading room in response to a request from a state health department for an evaluation of respiratory and skin symptoms among peanut inspectors. Reported symptoms included dermal (skin rash, burning/itching skin); respiratory (cough, shortness of breath, respiratory tract irritation, nosebleeds); and flu-like symptoms after being exposed to “bad” peanuts. We evaluated the workplace during two site visits 10 months apart. |
The identification of a sensitizing component used in the manufacturing of an ink ribbon
Anderson SE , Tapp L , Durgam S , Meade BJ , Jackson LG , Cohen DE . J Immunotoxicol 2012 9 (2) 193-200 Skin diseases including dermatitis constitute approximately 30% of all occupational illnesses, with a high incidence in the printing industry. An outbreak of contact dermatitis among employees at an ink ribbon manufacturing plant was investigated by scientists from the National Institute for Occupational Safety and Health (NIOSH). Employees in the process areas of the plant were exposed to numerous chemicals and many had experienced skin rashes, especially after the introduction of a new ink ribbon product. To identify the causative agent(s) of the occupational dermatitis, the murine local lymph node assay (LLNA) was used to identify the potential of the chemicals used in the manufacture of the ink ribbon to induce allergic contact dermatitis. Follow-up patch testing with the suspected allergens was conducted on exposed employees. Polyvinyl butyral, a chemical component used in the manufacture of the ink ribbon in question and other products, tested positive in the LLNA, with an EC3 of 3.6%, which identifies it as a potential sensitizer; however, no employees tested positive to this chemical during skin patch testing. This finding has implications beyond those described in this report because of occupational exposure to polyvinyl butyral outside of the printing industry. |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 18, 2025
- Content source:
- Powered by CDC PHGKB Infrastructure